0001140361-13-014964.txt : 20130401 0001140361-13-014964.hdr.sgml : 20130401 20130401194651 ACCESSION NUMBER: 0001140361-13-014964 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130328 FILED AS OF DATE: 20130401 DATE AS OF CHANGE: 20130401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASAR VINIT K CENTRAL INDEX KEY: 0001454324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 13732962 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2013-03-28 0 0000722723 HANGER, INC. HGR 0001454324 ASAR VINIT K 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 1 1 0 0 Chief Executive Officer Common Stock 2013-03-28 4 S 0 1772 31.4533 D 121308 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $31.28 to $31.6525. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares totaling 18,500 shares of stock from an initial grant of 18,500 shares of restricted stock made on March 11, 2013; (ii) unvested restricted shares totaling 17,250 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (iii) unvested restricted shares and fully vested shares totaling 24,630 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (iv) unvested restricted shares and fully vested shares totaling 12,679 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (v) unvested restricted shares and fully vested shares totaling 19,247 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; and [continued in next footnote] (vi) fully vested shares totaling 29,002 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar 2013-04-01